跳至主要内容
临床试验/KCT0008264
KCT0008264尚未招募Unknown

Randomized Controlled Trial of Intravascular Ultrasound Versus Fractional Flow Reserve for Non-infarct Related Artery Lesions in Patients with Multivessel Disease and Acute STEMIIntravascular Ultrasound Versus Fractional Flow Reserve for Non-infarct Related Artery Lesions in Patients with MultivEssel Disease and Acute STEMI(FRAME-AMI 2 Trial)

Samsung Medical Center0 个研究点目标入组 1,400 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
1,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • ?Subject must be at least 19 years of age
  • ?Acute ST-segment elevation myocardial infarction (STEMI)
  • *STEMI: ST-segment elevation =0.1 mV in =2 contiguous leads or documented newly developed left bundle-branch block1
  • ?Successful primary percutaneous coronary intervention (PCI) for IRA in <12 h after the onset of symptoms
  • ?Multivessel disease (at least one stenosis of >50% in a non-IRA =2.25 mm by visual estimation)
  • ?Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic evaluation and PCI and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.

排除标准

  • ?Non-IRA stenosis not amenable for PCI treatment by operators’ decision
  • ?Cardiogenic shock (Killip class IV) already at presentation or the completion of IRA PCI
  • ?Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparin, or Everolimus
  • ?Known true anaphylaxis to contrast medium (not allergic reaction but anaphylactic shock)
  • ?Pregnancy or breast feeding
  • ?Non-cardiac co-morbid conditions are present with life expectancy <2 year or that may result in protocol non-compliance (per site investigator’s medical judgment)
  • ?Other primary valvular disease with severe degree: severe mitral regurgitation, mitral stenosis, severe aortic regurgitation, or aortic stenosis
  • ?Unwillingness or inability to comply with the procedures described in this protocol.

研究者

相似试验